A Study of LY01008 and Bevacizumab Combined With Paclitaxel and Carboplatin for Treatment of Naïve Subjects With Metastatic or Recurrent Nonsquamous Non-small Cell Lung Cancer

NCT03533127 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

648

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer
Non Small Cell Lung Cancer Metastatic
Non Small Cell Lung Cancer Recurrent

Interventions

DRUG: LY01008
DRUG: Bevacizumab

Sponsor

Luye Pharma Group Ltd.